CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 mixed.
Replications
- NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD, Ip et al. (2021). Outcome recorded: mixed.
Responders defined by the iSPOT-D criteria showed a higher propensity toward low vigilance stages in comparison to patients with no response at pretreatment, however, this did not apply when using the NeuroPharm criteria.
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages